Login / Signup

Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia.

Anuschka Silva-SpínolaMarisa LimaMaria João LeitãoCatarina BernardesJoão DurãesDiana DuroMiguel Tábuas-PereiraIsabel SantanaInês Baldeiras
Published in: European journal of neurology (2023)
Our findings highlight the potential of combining blood-based GFAP, NfL, and p-Tau181 to be applied as a prognostic tool in MCI.
Keyphrases
  • mild cognitive impairment
  • cognitive decline
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • risk assessment
  • cerebrospinal fluid
  • climate change